查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844059

短讀定序市場按產品、技術、最終用戶和應用分類－2025-2032年全球預測

Short-read Sequencing Market by Product, Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，短讀定序市場將成長至 227.6 億美元，複合年成長率為 16.43%。

關鍵市場統計數據
基準年 2024 67.3億美元
預計年份：2025年 78.4億美元
預測年份 2032 227.6億美元
複合年成長率 (%) 16.43%

策略實施凸顯了短讀定序在研究、診斷和商業應用的商業和科學價值。

短讀長定序技術已從一項顛覆性的實驗室技術發展成為支撐現代分子生物學、臨床診斷和工業生物技術的基礎能力。化學、儀器和數據處理技術的進步，顯著提升了測序的通量、準確性和成本效益，使其能夠在科學研究、臨床和商業環境中常規應用。因此，從學術實驗室到大型製藥企業，相關人員都在重新思考工作流程、合作模式和資金配置，以便將主導定序的洞見融入其核心營運中。

本文透過將近期技術進步與實際應用成果連結起來，闡述了短讀長定序平台的策略重要性。短讀長定序方法具有高鹼基精度、成熟的生物資訊學生態系統，並且在標靶和全基因組分析中仍保持相對較低的成本。因此，即使長讀長定序技術在一些特定領域逐漸受到青睞，短讀長定序方法仍然是許多標準應用的首選。本文從技術細節和實際應用的觀點出發，重點闡述了試劑、設備和分析方法的迭代改進如何共同重塑決策格局。

透過這個觀點，讀者將了解短讀定序在哪些方面能帶來最大的增量價值，不同使用者群體採用此技術的模式有何差異，以及對於希望利用定序獲得競爭優勢的企業而言，哪些策略因應措施最為有效。接下來的章節將探討變革性轉變、政策影響、細分邏輯、區域差異、關鍵企業措施、可操作的建議以及調查方法，以支持穩健的決策。

快速的技術進步、軟體普及化以及不斷演進的服務模式正在重塑短讀測序技術的應用和價值交付方式

短讀長定序領域正經歷著一場變革性的轉變，這主要得益於技術、監管環境和市場力量的整合。化學方法和儀器設備的改進不斷提高讀取準確率，降低了批間差異，並簡化了樣本製備。同時，文庫製備試劑套件和流動池設計的進步也加快了定序結果的獲取速度，從而實現了臨床工作流程的快速週轉，並強化了定序儀在時間敏感型診斷中的作用。

同時，軟體創新和雲端原生生物資訊學流程正在普及高階分析技術，使小型實驗室也能應用複雜的變異檢測、轉錄本定量和元基因組分析。互通性和標準化資料格式促進了協作式和多中心研究，而儀器和試劑供應商之間的競爭則加速了產品開發週期，並擴展了服務範圍，例如整合的樣本到分析平台。

監管和報銷環境也在不斷演變，更嚴格的驗證要求和更清晰的診斷核准路徑鼓勵供應商投資強大的臨床應用價值。供應鏈最佳化和模組化經營模式（例如儀器即服務和試劑訂閱）也在重塑客戶關係。簡而言之，短讀定序生態系統正朝著更易於取得、更整合化和更多樣化的商業化模式轉變。

評估美國關稅政策在2025年之前的變化如何影響定序系統的供應鏈韌性、採購模式轉變和籌資策略。

美國在2025年前實施的新關稅和貿易措施，為依賴進口試劑、耗材和設備的企業帶來了重大的合規性和成本控制挑戰。這些政策變化迫使採購團隊和供應商重新評估籌資策略，考慮替代物流路線，並評估近岸外包和區域經銷夥伴，以減輕關稅造成的價格波動影響。隨著企業調整策略，他們越來越重視合約的彈性、多供應商資格認證和庫存管理，以維持業務永續營運。

為應對關稅壓力，一些製造商正在加快大批量耗材和關鍵部件的本地化生產，而服務提供者則在尋求增值物流解決方案，以保護終端用戶免受成本波動的影響。對供應鏈監管力度的增加也促使企業增加文件編制、供應商審核和可追溯性措施，從而延長了供應商資格資格確認流程的時間並增加了其複雜性。因此，實驗室和臨床應用機構的資本規劃週期現在已將與關稅相關的潛在進度和成本偏差納入考慮。

展望未來，關稅引發了關於供應鏈韌性、採購管治和策略性庫存狀況的更廣泛討論。積極拓展供應商基礎、在適當情況下進行提前採購、並與供應商合作開展本地生產和合約模式的企業，將更有利於在保持預算可預測性的同時，持續獲得測序試劑和設備。

整合細分洞察，揭示產品類型、排序技術、使用者畫像和應用模式的採用以及它們如何塑造價值鏈。

要了解市場動態，就需要清楚地理解產品、技術、終端用戶和應用如何相互作用，從而塑造需求和採用模式。耗材分為流動池和試劑以及文庫製備試劑套件；儀器分為桌上型定序儀和高通量定序儀；軟體和服務分為生物資訊學服務和數據分析軟體。這種產品層面的框架表明，流程依賴性和試劑的重複消耗驅動著經常性收入模式，而儀器的資本支出決策則取決於通量、佔地面積和整合能力。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合人工智慧驅動的變異檢測演算法，以提高短讀測序的準確性和通量。
  • 在樣品製備工作流程中提高自動化和機器人技術的應用，以實現高通量分析。
  • 擴展可攜式桌上型定序儀的應用範圍，以實現臨床微生物實驗室的照護現場基因檢測
  • 開發一種用於法醫學基因體學中微量和劣化DNA樣本的新型文庫製備試劑套件
  • 多重靶向序列捕獲板在經濟高效的綜合癌症突變分析中的應用日益廣泛
  • 定序服務供應商與雲端運算平台之間的合作，可實現即時數據分析的可擴展性
  • 監管機構的重點是規範定定序品質指標，以促進短讀長定序平台的臨床應用。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 短讀定序市場產品分類

  • 消耗品
    • 流動池和試劑
    • 文庫製備套件
  • 裝置
    • 桌上型音序器
    • 高通量定序儀
  • 軟體和服務
    • 生物資訊服務
    • 數據分析軟體

9. 按技術分類的短讀定序市場

  • 半導體定序
    • 離子質子
    • 離子激流 PGM
  • 定序連接
  • 定序合成

第10章 依最終用戶分類的短讀定序市場

  • 學術研究機構
  • 合約研究組織
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

第11章 按應用分類的短讀定序市場

  • 表觀基因
    • 染色質可及性分析
    • DNA甲基化分析
  • 基因組學
    • 重新排列
    • 標靶定序
    • 全基因組序列分析
  • 總體基因體學
  • 轉錄組學

12. 各地區的短讀定序市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 短讀定序市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國短讀定序市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Illumina, Inc.
    • BGI Genomics Co., Ltd.
    • Thermo Fisher Scientific Inc.
    • Novogene Co., Ltd.
    • Azenta, Inc.
    • Macrogen, Inc.
    • QIAGEN NV
    • Eurofins Scientific SE
    • Genetron Holdings Limited
    • Fulgent Genetics, Inc.
Product Code: MRR-AD36CD898498

The Short-read Sequencing Market is projected to grow by USD 22.76 billion at a CAGR of 16.43% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.73 billion
Estimated Year [2025] USD 7.84 billion
Forecast Year [2032] USD 22.76 billion
CAGR (%) 16.43%

A strategic introduction highlighting the operational and scientific relevance of short-read sequencing across research, diagnostics, and commercial applications

Short-read sequencing has matured from a disruptive laboratory technique into a foundational capability that underpins modern molecular biology, clinical diagnostics, and industrial biotechnology. Advances in chemistry, instrumentation, and data processing have pushed throughput, accuracy, and cost-efficiency to levels that enable routine deployment across research, clinical, and commercial environments. As a result, stakeholders ranging from academic laboratories to large pharmaceutical companies are rethinking workflows, partnering models, and capital allocation to integrate sequencing-driven insights into core operations.

This introduction frames the strategic importance of short-read platforms by linking recent technological improvements to practical outcomes. Short-read approaches continue to offer high per-base accuracy, established bioinformatics ecosystems, and relative affordability for targeted and whole-genome assays. Consequently, they remain the preferred option for many standard applications even as long-read technologies gain traction in niche areas. Throughout this document, we adopt a lens that balances technical nuance with operational relevance, emphasizing how iterative improvements in reagents, instrumentation, and analytics combine to reshape decision-making horizons.

Through this perspective, readers will gain an understanding of where short-read sequencing delivers the greatest incremental value, how adoption patterns differ by user profile, and which strategic responses are most effective for organizations seeking to leverage sequencing as a competitive advantage. The following sections unpack the transformative shifts, policy impacts, segmentation logic, regional distinctions, leading corporate behaviors, actionable recommendations, and the research methodology that together support robust decision-making.

How rapid technological refinements, software democratization, and evolving service models are reshaping short-read sequencing adoption and value delivery

The landscape of short-read sequencing is experiencing transformative shifts driven by converging technological, regulatory, and market forces. Chemistry and instrument refinements have steadily improved read accuracy, reduced run-to-run variability, and simplified sample preparation, which collectively lower barriers to adoption in decentralized settings. Parallel advances in library preparation kits and flow cell design have shortened time-to-answer and enabled faster turnaround in clinical workflows, reinforcing sequencing's role in time-sensitive diagnostics.

At the same time, software innovations and cloud-native bioinformatics pipelines are democratizing access to advanced analysis, allowing smaller laboratories to apply complex variant calling, transcript quantification, and metagenomic profiling. Interoperability and standardized data formats are facilitating collaborative research and multi-center studies. Meanwhile, the competitive dynamic among instrument and reagent providers is accelerating product development cycles and expanding service offerings such as integrated sample-to-insight platforms.

Regulatory and reimbursement environments are also evolving; stricter validation requirements coexist with clearer pathways for diagnostic approval, which incentivizes vendors to invest in robust clinical utilities. Supply chain optimization and modular business models, including instrument-as-a-service and reagent subscriptions, are reshaping customer relationships. In short, the short-read sequencing ecosystem is shifting toward greater accessibility, higher integration, and more diverse commercialization models that collectively broaden its impact across scientific and clinical domains.

Assessing how United States tariff changes for 2025 are driving supply chain resilience, sourcing shifts, and procurement strategies across the sequencing ecosystem

The imposition of new tariffs and trade measures in the United States for 2025 has introduced a material compliance and cost-management dimension for organizations that rely on imported reagents, consumables, and instrumentation. These policy changes have prompted procurement teams and suppliers to reassess sourcing strategies, consider alternative logistics pathways, and evaluate nearshoring or regional distribution partnerships to mitigate exposure to tariff-driven price variability. As companies adjust, they increasingly emphasize contractual flexibility, multi-supplier qualification, and inventory management to sustain operational continuity.

In response to tariff pressures, some manufacturers have accelerated localization of production for high-volume consumables and critical components, while service providers have explored value-added logistics solutions to shield end users from sudden cost shifts. Regulatory scrutiny of supply chains has also risen, prompting enhanced documentation, supplier audits, and traceability measures that extend the timeline and complexity of vendor qualification processes. Consequently, capital planning cycles for laboratories and clinical adopters now account for potential tariff-related schedule and cost deviations.

Looking forward, the tariffs have catalyzed broader conversations about supply chain resilience, procurement governance, and strategic inventory posture. Organizations that proactively diversify supplier bases, engage in forward purchasing where appropriate, and collaborate with vendors on localized production and consignment models are better positioned to maintain consistent access to sequencing reagents and instruments while preserving budget predictability.

Integrated segmentation insights revealing how product types, sequencing technologies, user profiles, and application modalities together shape adoption and value chains

Understanding market dynamics requires a clear view of how products, technologies, end users, and applications intersect to shape demand and adoption patterns. Based on product, the market is examined across Consumables, Instruments, and Software & Services with Consumables further segmented into Flow Cells & Reagents and Library Prep Kits, Instruments separated into Benchtop Sequencers and High-Throughput Sequencers, and Software & Services divided into Bioinformatics Services and Data Analysis Software. This product-level framing reveals that procedural dependencies and recurring reagent consumption drive recurring revenue models, while instrument capital expenditure decisions hinge on throughput, footprint, and integration capability.

Based on technology, the landscape is charted across Semiconductor Sequencing, Sequencing Ligation, and Sequencing Synthesis, with Semiconductor Sequencing further characterized by platforms such as Ion Proton and Ion Torrent PGM. Each technology presents distinct trade-offs in read length, throughput, and run economics, which influence suitability for specific applications. Based on end user, the market encompasses Academic & Research Institutes, Contract Research Organizations, Hospitals & Diagnostic Labs, and Pharma & Biotech Companies, and this segmentation clarifies how purchasing cycles, validation demands, and service expectations vary across institutions.

Based on application, the analysis addresses Epigenomics, Genomics, Metagenomics, and Transcriptomics, further detailing Epigenomics into Chromatin Accessibility Analysis and DNA Methylation Analysis, and Genomics into Resequencing, Targeted Sequencing, and Whole Genome Sequencing. This application-focused perspective underscores how analytical priorities-such as depth versus breadth of coverage, sensitivity for rare variants, and throughput-determine the optimal constellation of products and services for a given use case. Integrating these segmentation lenses enables more precise market positioning, technology roadmapping, and customer engagement strategies.

Regional dynamics and policy environments explain distinct adoption pathways and vendor strategies across the Americas, EMEA, and Asia-Pacific markets

Regional dynamics play a central role in shaping the deployment, regulatory acceptance, and commercial strategies for short-read sequencing. In the Americas, robust research infrastructure, wide availability of clinical trial networks, and relatively mature reimbursement pathways support rapid translation of sequencing into diagnostics and therapeutics discovery. The concentration of biotech hubs and large-scale sequencing centers creates demand for both high-throughput instruments and sophisticated bioinformatics services, while procurement practices emphasize service-level guarantees and long-term vendor partnerships.

In Europe, Middle East & Africa, regulatory diversity and varying levels of infrastructure investment create a heterogeneous adoption landscape. Western European markets often prioritize hospital integration and clinical validation pathways, whereas emerging markets in the region show strong academic research uptake and increasing interest from public health programs. Strategic partnerships that include training, local technical support, and adaptive pricing models accelerate broader adoption across these varied contexts. Regulatory harmonization efforts and cross-border research consortia are progressively smoothing integration challenges.

In Asia-Pacific, rapid capacity building, government-supported genomics initiatives, and strong manufacturing capabilities are accelerating both demand and local supply. High-throughput sequencing applications tied to population-scale studies and genomics-driven drug discovery are prominent, and regional providers are increasingly competitive on cost, localization, and scale. Across all regions, geographic considerations inform choices about inventory buffers, training programs, and deployment models, and vendors that tailor offerings to regional needs and policy environments gain a strategic advantage.

How leading companies combine instrument innovation, consumable reliability, and analytics services to build integrated platforms and durable customer relationships

Companies at the forefront of short-read sequencing are differentiating through integrated platform capabilities, expanded service offerings, and strategic partnerships that accelerate clinical adoption. Leading instrument manufacturers continue to iterate on throughput, run-time, and automation features, while reagent and consumable producers focus on lot-to-lot consistency, supply chain transparency, and streamlined workflows that reduce operator dependency. Service and software providers that deliver validated pipelines, interpretive reporting, and secure data management are becoming indispensable, especially for clinical and regulatory use cases.

Competitive positioning now extends beyond hardware to include recurring revenue models, cloud-enabled analytics, and co-development arrangements with large academic centers and pharmaceutical customers. As a result, some vendors are bifurcating their business models to serve high-throughput central laboratories while offering simplified benchtop solutions for point-of-care and smaller research settings. Partnerships with contract research organizations and localized distribution networks help many companies scale internationally while maintaining compliance and technical support standards.

Strategic acquisitions, collaborative development agreements, and investments in manufacturing redundancy are common tactics companies use to secure supply continuity and broaden technological portfolios. Firms that emphasize interoperability, open data standards, and comprehensive customer education programs earn greater trust among institutional buyers and clinical laboratories, which in turn supports deeper long-term relationships and recurring business.

Actionable recommendations for industry leaders to enhance supply resilience, customer-centric offerings, and clinical validation pathways that drive sustained adoption

Industry leaders should prioritize actions that balance near-term operational resilience with long-term strategic positioning. First, strengthening supply chain diversity and establishing regional manufacturing or distribution partnerships will reduce exposure to tariff and logistics volatility while improving service responsiveness. Second, investing in validated, user-friendly workflows-spanning sample prep, run automation, and standardized analytics-will lower the barrier to adoption across clinical and decentralized research settings and accelerate time-to-impact.

Third, building modular business models that offer both capital acquisition and subscription-based reagent or software services creates more predictable revenue streams and aligns vendor incentives with customer success. Fourth, companies should deepen collaborations with clinical networks and regulatory bodies to co-develop validation datasets and diagnostic use cases, thereby reducing time-to-market for clinical assays. Fifth, focusing on data interoperability, privacy-compliant cloud frameworks, and interpretive reporting will make sequencing outputs actionable for clinicians and researchers alike.

Finally, leaders must invest in workforce enablement through training, certification, and localized technical support to ensure customers achieve consistent, high-quality results. By combining operational robustness with customer-centric product development and collaborative validation pathways, organizations can capture greater strategic value from the expanding role of short-read sequencing in science and medicine.

Transparent research methodology combining primary interviews, secondary source triangulation, and cross-segmentation analysis to ensure reliable and actionable insights

The research underpinning this analysis integrates qualitative and quantitative approaches to ensure robust, reproducible insights. Primary research included structured interviews with executives, laboratory directors, procurement leads, and technical specialists across academic, clinical, and commercial institutions. These interviews provided firsthand perspectives on adoption drivers, validation requirements, procurement behaviors, and operational pain points, which informed thematic synthesis and scenario analysis.

Secondary research encompassed peer-reviewed literature, regulatory guidance documents, company technical specifications, white papers, and public disclosures that describe technological capabilities, workflow performance metrics, and deployment case studies. Comparative evaluation of these sources enabled triangulation of product characteristics, application suitability, and commercial strategies. Where appropriate, supplier documentation and open data repositories were cross-referenced to validate performance claims and identify reproducibility considerations.

Analytical methods included cross-segmentation mapping to reveal alignment between product offerings and application needs, sensitivity assessments to explore the operational impact of policy and supply chain shifts, and stakeholder impact mapping to prioritize recommendations. Rigorous quality controls-such as interview validation, source corroboration, and iterative peer review-were applied throughout the research lifecycle to maintain accuracy and practical relevance for decision-makers.

Concluding synthesis that connects technological maturity, operational resilience, and collaborative strategies to realize the value of short-read sequencing

In conclusion, short-read sequencing stands at the intersection of mature technical capability and expanding application breadth, offering a pragmatic balance between accuracy, throughput, and established analytical ecosystems. The technology's continued refinement in reagents, instrument automation, and data analysis is broadening its applicability from core research laboratories to clinical and industrial settings. Simultaneously, external forces such as regulatory evolution and tariff-driven supply chain adjustments are prompting stakeholders to adopt more resilient procurement and validation practices.

The cumulative picture is one of steady integration: vendors that deliver interoperable, validated workflows and resilient supply strategies will realize greater adoption, while customers that prioritize standardized processes and training will extract more consistent value from their investments. Strategic partnerships across manufacturers, service providers, and end users accelerate the translation of sequencing capabilities into actionable insights for diagnostics, drug discovery, and public health surveillance. By aligning technological choices with operational realities and regulatory requirements, organizations can harness short-read sequencing to advance scientific goals and clinical outcomes.

This document synthesizes the core dynamics shaping the ecosystem and outlines practical steps for stakeholders seeking to optimize technology selection, supply continuity, and application deployment in the near term and beyond.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven variant calling algorithms to improve short-read sequencing accuracy and throughput
  • 5.2. Rising adoption of automation and robotics in sample preparation workflows for high-throughput short-read sequencing
  • 5.3. Expansion of portable benchtop sequencers enabling point-of-care genetic testing in clinical microbiology labs
  • 5.4. Development of novel library preparation kits for ultra-low input and degraded DNA samples in forensic genomics
  • 5.5. Increased use of multiplexed target enrichment panels for comprehensive cancer mutation profiling at lower costs
  • 5.6. Collaboration between sequencing providers and cloud computing platforms for real-time data analysis scalability
  • 5.7. Regulatory focus on standardization of sequencing quality metrics to facilitate clinical adoption of short-read platforms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Short-read Sequencing Market, by Product

  • 8.1. Consumables
    • 8.1.1. Flow Cells & Reagents
    • 8.1.2. Library Prep Kits
  • 8.2. Instruments
    • 8.2.1. Benchtop Sequencers
    • 8.2.2. High-Throughput Sequencers
  • 8.3. Software & Services
    • 8.3.1. Bioinformatics Services
    • 8.3.2. Data Analysis Software

9. Short-read Sequencing Market, by Technology

  • 9.1. Semiconductor Sequencing
    • 9.1.1. Ion Proton
    • 9.1.2. Ion Torrent PGM
  • 9.2. Sequencing Ligation
  • 9.3. Sequencing Synthesis

10. Short-read Sequencing Market, by End User

  • 10.1. Academic & Research Institutes
  • 10.2. Contract Research Organizations
  • 10.3. Hospitals & Diagnostic Labs
  • 10.4. Pharma & Biotech Companies

11. Short-read Sequencing Market, by Application

  • 11.1. Epigenomics
    • 11.1.1. Chromatin Accessibility Analysis
    • 11.1.2. DNA Methylation Analysis
  • 11.2. Genomics
    • 11.2.1. Resequencing
    • 11.2.2. Targeted Sequencing
    • 11.2.3. Whole Genome Sequencing
  • 11.3. Metagenomics
  • 11.4. Transcriptomics

12. Short-read Sequencing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Short-read Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Short-read Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Illumina, Inc.
    • 15.3.2. BGI Genomics Co., Ltd.
    • 15.3.3. Thermo Fisher Scientific Inc.
    • 15.3.4. Novogene Co., Ltd.
    • 15.3.5. Azenta, Inc.
    • 15.3.6. Macrogen, Inc.
    • 15.3.7. QIAGEN N.V.
    • 15.3.8. Eurofins Scientific SE
    • 15.3.9. Genetron Holdings Limited
    • 15.3.10. Fulgent Genetics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SHORT-READ SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY FLOW CELLS & REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BENCHTOP SEQUENCERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HIGH-THROUGHPUT SEQUENCERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION PROTON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ION TORRENT PGM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING LIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING SYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CHROMATIN ACCESSIBILITY ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DNA METHYLATION ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY RESEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY SEMICONDUCTOR SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY EPIGENOMICS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE SHORT-READ SEQUENCING MARKET SIZE, BY GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)

TABLE